Clinical Trial Update: Phase 2c Dose Comparison Study of MP4OX in Trauma [Phase 2]

View source ↗

Summary

A Phase 2c dose-comparison trial of MP4OX in trauma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock
• Lactic Acidosis
• Trauma

Drugs mentioned

• MP4OX

Snippet

Sponsor: Sangart | Conditions: Trauma, Hemorrhagic Shock | Phase 2 | Status: WITHDRAWN